• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

J&J homes in on manufacturing restart at Emergent plant behind 15M discarded COVID-19 doses

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 29, 2021 at 05:22: PM
via With production on pause and millions of COVID-19 vaccine doses in limbo, Johnson & Johnson has been hustling to right the ship at CDMO Emergent BioSolutions' troubled Baltimore manufacturing facility. Now, it looks as if relief is in sight.

article source
 

<



Similar threads

cafead
At J&amp;J, oncology R&amp;D meets commercial strategy in a quest for new standards of care
Replies
0
Views
9
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Agency warns J&amp;J over 340B rebate plan
Replies
0
Views
23
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
ESMO: J&amp;J cues up phase 3 for Rybrevant in colorectal cancer
Replies
0
Views
4
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA pushed to be more open, collaborative to accelerate rare disease R&amp;D
Replies
0
Views
6
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Moderna targets $1.1B in R&amp;D spending cuts, drops 5 programs amid profitability pressures
Replies
0
Views
38
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote